Naobios

Naobios is a GMP-certified contract development and manufacturing organization (CDMO) located in Saint-Herblain, France. Established in 2005, the company specializes in bioprocess development and the manufacturing of preclinical and clinical batches for virus-based biopharmaceuticals. This includes viral vectors, vaccines, oncolytic viruses, and viral challenge agents. With over 15 years of expertise, Naobios has evolved through acquisitions and rebranding, expanding its capabilities to support innovative therapies in genetic diseases, oncology, infectiology, and immunology.

The company offers a comprehensive range of GMP-compliant services, including bioprocess development, manufacturing of investigational products, and analytical quality services. Naobios handles various scales of production, from small preclinical batches to larger commercial-scale manufacturing. Their facilities include a BSL3 manufacturing unit for high-risk products, and they utilize advanced technologies such as automated systems and high-throughput microbioreactors. Naobios is dedicated to supporting global sponsors in the development of virus-based therapies.